Form 4: DENTSPLY SIRONA Director Buys 9,337 Shares

DENTSPLY SIRONA Inc. Director Leslie F. Varon acquired 9,337 shares of common stock at $10.71 per share, increasing beneficial ownership.

Summary

• Leslie F. Varon, a Director of DENTSPLY SIRONA Inc. (XRAY), purchased 9,337 shares of common stock.
• The transaction occurred on November 24, 2025, at a price of $10.71 per share.
• Following this acquisition, Leslie F. Varon beneficially owns a total of 57,342.925 shares of DENTSPLY SIRONA Inc. common stock.
• The purchase was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The purchase of company stock by a director typically signals confidence in the company's current valuation and future prospects, which is generally viewed as a positive indicator by the market.

Positives

• A director's purchase of company stock can signal confidence in the company's future prospects and valuation.
• The acquisition increases the director's alignment with shareholder interests.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

Insider buying, particularly by a director, can be viewed positively by the market as it suggests confidence in the company's valuation and future performance within the dental products and technologies industry. Such transactions are often monitored by investors for signals regarding management's perception of the company's intrinsic value.

Comparison to Industry Standards

• This filing reports an insider transaction, which is a standard disclosure requirement. There are no specific company or project results to compare against global benchmarks or specific comparable companies within this filing.

Stakeholder Impact

• Shareholders: May view the director's purchase as a positive signal of confidence, potentially influencing investor sentiment.
• Management: Increased alignment between the director's personal financial interests and the company's performance.

Key Dates

Recommendation

While the director's purchase of shares is a positive signal of confidence in DENTSPLY SIRONA's future, a single insider transaction typically warrants a 'hold' recommendation rather than a 'buy' or 'strong buy' without further comprehensive financial analysis of the company's fundamentals, market conditions, and strategic outlook. It reinforces the belief in the company's value but doesn't fundamentally alter the investment thesis on its own.

Keywords

DENTSPLY SIRONA, XRAY, Insider Buy, Director Stock Purchase, Leslie F. Varon, Form 4, Stock Acquisition, Beneficial Ownership, Rule 10b5-1